Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study
2016 ◽
Vol 128
(3)
◽
pp. 405-415
◽
2005 ◽
Vol 25
(1_suppl)
◽
pp. S274-S274
2018 ◽
Vol 14
(4)
◽
pp. 359-367
◽